Lack of effect of leptin on the behaviour of mice predicting the level of anxiety and depression

Pharmacology and Toxicology

Volumn 83, Issue 3, 1998, Pages 139-142

  Suomalainen, Maija ^a   Männistö, Pekka T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; NEUROPEPTIDE Y;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; APPETITE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ANTAGONISM; DRUG EFFECT; FEEDING BEHAVIOR; MOUSE; NONHUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031664910     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01458.x     Document Type: Article

References (13)

1. Campfield, L. A., F. J. Smith, Y. Guisez, R. Devos & P. Burn: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural network. Science 1995, 269, 546-549.
2. Campfield, L. A., F. J. Smith & P. Burn: The OB protein (leptin) pathway - A link between adipose tissue mass and central neural networks. Horm. Metab. Res. 1996, 28, 619-632.
3. Crawley, J. N. & F. K. Goodwin: Preliminary report of simple animal model for anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 1980, 13, 167-170.
4. Deuschle, M., W. F. Blum, P. Englaro, L. Schweiger, B. Weber, C. D. Pflaum & I. Heuser: Plasma leptin in depressed patients and healthy controls. Horm. Metab. Res. 1996, 28, 714-717.
5. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabodowitz, R. L. Lollone, S. K. Bureley & J. M. Friedman: Weight reducing effect of the plasma protein encoded by the obese gene. Science 1995, 269, 543-546.
6. Handley, S. L. & S. Mithani: Effects of α-adrenergic agonists and antagonists in a maze-exploration model of "fear"-motivated behaviour. Naunyn-Schmied. Arch. Pharmacol. 1984, 327, 1-5.
7. Heilig, M. & R. Murison: Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul. Pept. 1987, 19, 221-231.
8. Heiman, M. L., R. S. Ahima, L. S. Craft, B. Schoner, T. W. Stephens & J. S. Flier: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997, 138, 3859-3863.
9. Maness, L. M., W. A. Banks & A. J. Kastin: Investigation of blood-brain barrier penetration and central nervous system distribution of peptides and proteins by in vivo autoradiography. Stp Pharma Sci. 1997, 7, 12-16.
10. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone & F. Collins: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269, 540-543.
11. Porsolt, R. D., A. Bertin & M. Jalfre: Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Therap. 1977, 229, 327-336.
12. Stephens, T. W., M. Basinski & P. K. Bristow: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995, 377, 530-532.
13. 3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze. Psychopharmacology 1993, 110, 213-218.